
Jessica Dai, BS
Experts, including Jamie Collins, PhD, will explain how investigators and clinicians can leverage a key element in artificial intelligence models to read, interpret, and apply new research.
Tanaz Kermani, MD, MS, and Wolfgang Schmidt, MD, MACR, will debate whether and when to perform a biopsy to diagnose one of the most common forms of vasculitis in adults, and whether ultrasound can preclude the need to perform biopsies.
A multidisciplinary panel, including Renuka Nayak, MD, PhD, will review clinical and translational aspects of GI tract involvement in autoimmune rheumatic diseases. Research suggests that gut microorganisms may influence both the development of rheumatoid arthritis and response to treatment.
An interactive, game-based session on Tuesday morning will focus on two core diseases: juvenile myositis and vasculitis. Coordinators Susan Shenoi, MD, MS, and Pui Lee, MD, PhD, preview the friendly competition.
Anne Davidson, MBBS, FRACP, shared recent literature furthering the fundamental science of rheumatology, including the use of artificial intelligence in drug development, while Bryant England, MD, PhD, detailed new developments in clinical science that have been published in the past year, including Sjögren’s disease terminology.
Basia Belza, RN, PhD, opened the session with clinical highlights. She was joined by Marian Hannan, DSc, MPH, who focused on basic science, and Carol Oatis, PhD, PT, who discussed rehabilitation.
Michael Weinblatt, MD, will outline how past approaches, such as gold therapy in the 1930s, and the advanced biologics being used today have laid the groundwork for future rheumatoid arthritis therapies.